Current studentsExisting staffContact us
 

O161 Using DCE to assess adherence and treatment preferences for combination therapies for cardiovascular disease

Simple item page
dc.contributor.authorLaba, T.L.
dc.contributor.authorHoward, K.
dc.contributor.authorJan, S.
dc.contributor.conferenceWorld Congress of Cardiology Scientific Sessions 2014 (4 May 2014 - 7 May 2014 : Australia)
dc.date.issued2014
dc.description.abstractDiscrete Choice Experiment (DCE) is a preference elicitation method used to value healthcare technologies. Kanyini-GAP (KGAP), a pragmatic clinical trial, assessed a polypill-based strategy on patient adherence to cardiovascular disease (CVD) treatment in Indigenous and non-Indigenous Australians. In this context DCE could help understand patient preferences for treatment, assisting with clinical evidence translation.
dc.identifier.citationGlobal Heart, 2014, vol.9, iss.1, supplement 1, pp.44-
dc.identifier.doi10.1016/j.gheart.2014.03.1367
dc.identifier.issn2211-8160
dc.identifier.urihttps://hdl.handle.net/11541.2/117632
dc.language.isoen
dc.publisherElsevier
dc.publisher.placeNetherlands
dc.rightsCopyright 2014 Published by Elsevier
dc.source.urihttps://doi.org/10.1016/j.gheart.2014.03.1367
dc.subjectcardiovascular disease
dc.subjectclinical trial
dc.subjecttreatment
dc.titleO161 Using DCE to assess adherence and treatment preferences for combination therapies for cardiovascular disease
dc.typeConference item
pubs.publication-statusPublished
ror.mmsid9916018507901831

Files

Collections